Clinical Translation &

 At Houston Methodist, our deep commitment to finding new ways to prevent and treat illness so as to improve the health of our patients means that our primary goal is to make a clinical trial available to every person who needs and wants to participate in one. Houston Methodist monitors more than 300 clinical protocols; while not all of them are actively enrolling patients at this time, many are, with new ones being opened every month.

The Cockrell Centers for Advanced Therapeutics are located throughout the greater Houston metro area. They provide services, staffing and facilities to physicians for conducting internally and externally sponsored clinical research close to their practices. The Cockrell Centers also offer a Clinical Research Phase 1 Unit located in the Texas Medical Center that can conduct advanced pharmacokinetic or pharmacodynamic evaluations for early-phase and proof-of-concept clinical trials.

Our clinical research services for physicians and research investigators include:

  • Research outpatient services
  • Regulatory and budget management
  • Private rooms for infusion
  • Fully equipped specimen processing laboratory
  • Adjacent state-of-the-art inpatient services, including critical care monitoring
  • Secure storage, preparation, and dispensing services for investigational products with 24/7 temperature monitoring
  • Pharmacokinetic and pharmacodynamic sampling (extended hours)

Unique atrial fibrillation technique in trial


A unique clinical trial led by Miguel Valderrabano, MD, developed a special technique to perform rapid ablation of atrial tissues using ethanol infusion and may help prevent a repeat procedure for persistent atrial fibrillation in some patients. Learn More.

Clinical Research Phase I Unit

The Clinical Research Phase 1 Unit located at our Texas Medical Center campus supports early phase I and II clinical trials and offers advanced pharmacokinetic and pharmacodynamic evaluations. Learn More.

Impact of Omega 3 Fatty Acids on Breast Cancer Patients

A study to assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients is underway. Learn More.

Safety and Performance of a device for cardiogenic shock

A clinical trial to evaluate the safety and effectiveness of the HeartMate III Left Ventricular Assist System is the largest of its kind. Learn More

Live Chat Available